右美托咪定后处理对猪心脏骤停复苏后心脏和神经结局的影响
研究纳入了28头雄性家猪,随机分为假手术组、心肺复苏组、低剂量右美托咪定后处理组和高剂量右美托咪定后处理组。模型采用8分钟心脏骤停后5分钟心肺复苏,复苏成功后低剂量组静脉注射0.25 μg/kg负荷量后以0.25 μg/kg/h持续输注6小时,高剂量组给予双倍剂量。结果显示,两个右美托咪定组的心脏和神经损伤严重程度均显著轻于心肺复苏组,且高剂量组的保护效应显著大于低剂量组。作者结论认为,右美托咪定后处理通过抑制组织炎症、氧化应激和细胞凋亡及坏死性凋亡,剂量依赖性地改善复苏后心脏和神经结局。
要点
- 在猪心脏骤停复苏模型中,右美托咪定后处理(0.25 μg/kg负荷后0.25 μg/kg/h输注6小时)显著减轻复苏后心脏和神经损伤。
- 高剂量右美托咪定后处理组(双倍剂量)的心脏和神经保护效应显著大于低剂量组,提示剂量依赖性。
- 右美托咪定后处理显著降低复苏后心脏和脑组织的炎症、氧化应激以及细胞凋亡和坏死性凋亡。
- 所有经历心脏骤停和复苏的动物均出现显著重于假手术组的心脏和神经功能障碍及损伤。
- 该研究为猪动物实验,共28头雄性家猪,结果不能直接转化为临床推荐。
适用人群与场景
- 雄性家猪,经历8分钟心脏骤停后5分钟心肺复苏并成功复苏的动物模型。
- 假手术组仅接受外科准备,不经历心脏骤停和复苏。
处置流程与药物剂量
- 低剂量右美托咪定后处理组:复苏成功后静脉注射负荷剂量0.25 μg/kg,随后以0.25 μg/kg/h持续输注6小时。
- 高剂量右美托咪定后处理组:给予双倍剂量右美托咪定,给药方式与低剂量组相同(负荷后持续输注6小时)。
- 心肺复苏组和假手术组给予等量生理盐水。
- 所有复苏动物监测6小时后返回笼中继续观察18小时。
研究设计与关键结果
- 研究类型为动物随机对照实验,共28头雄性家猪,随机分为假手术组、心肺复苏组、低剂量右美托咪定后处理组和高剂量右美托咪定后处理组。
- 与假手术组相比,所有经历心脏骤停和复苏的动物均出现显著更严重的心脏和神经功能障碍及损伤。
- 两个右美托咪定后处理组的心脏和神经损伤严重程度均显著轻于心肺复苏组。
- 右美托咪定后处理组复苏后心脏和脑组织的炎症、氧化应激以及细胞凋亡和坏死性凋亡均显著低于心肺复苏组。
- 高剂量右美托咪定后处理组的保护效应显著大于低剂量组。
证据类型、等级与局限
- 证据类型:动物随机对照实验(猪心脏骤停复苏模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,右美托咪定后处理通过抑制组织炎症、氧化应激和细胞凋亡及坏死性凋亡,剂量依赖性地改善复苏后心脏和神经结局。
- 该研究为猪动物实验,结果不能直接作为急诊或ICU临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: One of the main contents of post-resuscitation care is to alleviate cardiac and neurological damage in cardiac arrest (CA) victims. Recently, dexmedetomidine pre- and post-conditioning have been shown to both effectively protect the heart and brain against regional ischemia reperfusion injury. In this study, we investigated the effects of dexmedetomidine post-conditioning on cardiac and neurological outcomes after CA and resuscitation in swine.
METHODS: A total of 28 male domestic swine were randomized into four groups: sham, cardiopulmonary resuscitation (CPR), low-dose dexmedetomidine post-conditioning (LDP), and high-dose dexmedetomidine post-conditioning (HDP). Sham animals underwent the surgical preparation only. The animal model was established by 8 min of CA and then 5 min of CPR. After the animal was successfully resuscitated, a loading dose of 0.25 μg/kg of dexmedetomidine was intravenously injected followed by continuous infusion of 0.25 μg/kg/h for 6 h in the LDP group, and meanwhile a double dose of dexmedetomidine was similarly administered in the HDP group. The same amount of saline was given in the other two groups. All the resuscitated animals were monitored for 6 h and then returned to their cages for an additional 18 h of observation.
RESULTS: After resuscitation, significantly greater cardiac, neurological dysfunction, and injuries were observed in all animals experiencing CA and resuscitation when compared with the sham group. However, the severity of cardiac and neurological damage was significantly milder in the two dexmedetomidine-treated groups than in the CPR group. Dexmedetomidine post-conditioning also significantly decreased post-resuscitation tissue inflammation, oxidative stress, and cell apoptosis and necroptosis in the heart and brain when compared with the CPR group. In addition, these protective effects produced by dexmedetomidine post-conditioning were significantly greater in the HDP group than in the LDP group.
CONCLUSIONS: Dexmedetomidine post-conditioning dose-dependently improved post-resuscitation cardiac and neurological outcomes through the inhibition of tissue inflammation, oxidative stress, and cell apoptosis and necroptosis.
参考来源
- Shen R, Pan D, Wang Z, et al. The Effects of Dexmedetomidine Post-Conditioning on Cardiac and Neurological Outcomes After Cardiac Arrest and Resuscitation in Swine. Shock. 2021. PMID: 32925602. doi:10.1097/SHK.0000000000001637
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。